BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31687921)

  • 1. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.
    Andreotti RF; Timmerman D; Strachowski LM; Froyman W; Benacerraf BR; Bennett GL; Bourne T; Brown DL; Coleman BG; Frates MC; Goldstein SR; Hamper UM; Horrow MM; Hernanz-Schulman M; Reinhold C; Rose SL; Whitcomb BP; Wolfman WL; Glanc P
    Radiology; 2020 Jan; 294(1):168-185. PubMed ID: 31687921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ovarian/Adnexal Reporting and Data System for Ultrasound: From Standardized Terminology to Optimal Risk Assessment and Management.
    Phillips CH; Guo Y; Strachowski LM; Jha P; Reinhold C; Andreotti RF
    Can Assoc Radiol J; 2023 Feb; 74(1):44-57. PubMed ID: 35831958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-RADS for Ultrasound: A User's Guide, From the
    Strachowski LM; Jha P; Chawla TP; Davis KM; Dove CK; Glanc P; Morgan TA; Andreotti RF
    AJR Am J Roentgenol; 2021 May; 216(5):1150-1165. PubMed ID: 33355485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Validation of O-RADS US Risk Stratification and Management System.
    Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
    Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
    Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
    Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.
    Jha P; Gupta A; Baran TM; Maturen KE; Patel-Lippmann K; Zafar HM; Kamaya A; Antil N; Barroilhet L; Sadowski EA
    JAMA Netw Open; 2022 Jun; 5(6):e2216370. PubMed ID: 35679042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-RADS Ultrasound Version 1: A Scenario-Based Review of Implementation Challenges.
    Gargan ML; Frates MC; Benson CB; Guo Y
    AJR Am J Roentgenol; 2022 Dec; 219(6):916-927. PubMed ID: 35856453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
    Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
    Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee.
    Andreotti RF; Timmerman D; Benacerraf BR; Bennett GL; Bourne T; Brown DL; Coleman BG; Frates MC; Froyman W; Goldstein SR; Hamper UM; Horrow MM; Hernanz-Schulman M; Reinhold C; Strachowski LM; Glanc P
    J Am Coll Radiol; 2018 Oct; 15(10):1415-1429. PubMed ID: 30149950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
    Sadowski EA; Thomassin-Naggara I; Rockall A; Maturen KE; Forstner R; Jha P; Nougaret S; Siegelman ES; Reinhold C
    Radiology; 2022 Apr; 303(1):35-47. PubMed ID: 35040672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
    Shi Y; Li H; Wu X; Li X; Yang M
    J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee.
    Strachowski LM; Jha P; Phillips CH; Blanchette Porter MM; Froyman W; Glanc P; Guo Y; Patel MD; Reinhold C; Suh-Burgmann EJ; Timmerman D; Andreotti RF
    Radiology; 2023 Sep; 308(3):e230685. PubMed ID: 37698472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI.
    Suarez-Weiss KE; Sadowski EA; Zhang M; Burk KS; Tran VT; Shinagare AB
    Radiographics; 2023 Jul; 43(7):e220142. PubMed ID: 37319025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.